Our objective is to report the functional and oncologic outcomes of a cohort of 250 consecutive prostate cancer patients undergoing a Retzius-sparing approach and to assess for racial differences in continence outcomes.
Living kidney donation is the best treatment for end-stage renal disease, however, the best surgical approach for minimally-invasive donor nephrectomy (DN) is still a matter of debate. This bi-centric study aimed to retrospectively compare perioperative outcomes and postoperative kidney function after 257 transperitoneal DNs including 52 robot-assisted (RDN) and 205 laparoscopic DNs (LDN).
{{header-clinical-trials-navigation}} A Phase Ib, Open-Label, Multicenter Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer. Condition: Castration-Resistant Prostatic Cancer Study Type: Interventional Clinical Trials Identifier NCT 8-digits: NCT04404140 Sponsor: Hoffmann-La Roche Phase: Phase 1 Eligibility: Age: minimum 18 Years maximum N/A Gender: Male Inclusion […]
Broaden your experience, enrich your knowledge, and get to know peers from halfway across the world. Join the new scholarship programme of the European Association of Urology (EAU) and the Society of Urologic Oncology (SUO) by sending your application now. This year, as a selected EAU member you will begin your scholarship experience by attending […]
Over the past few weeks, the EAU’s Scientific Congress Office under Prof. Albers has been developing an all-online edition of the Annual EAU Congress. Many of the state-of-the-art lectures, case discussions and surgery sessions will be now be taking place during EAU20 Virtual, an intense three-day programme on Friday, Saturday and Sunday, 17-19 July. With […]
“Prostate cancer is a silent killer of men across Europe, with men often almost having to apologise for asking for better care,” opened Prof. James N’Dow (GB), EAU Guidelines Office chair, as he moderated a session on early detection of prostate cancer in a virtual conference organised by the European Alliance of Personalised Medicine (EAPM). […]
With COVID-19 being at the centre of the world medical stage, we see that many urological cancer patients are worried about the consequences of COVID-19 on their treatment. EAU Patient Information is anticipating this global need for accurate and trustworthy information and has started collecting Frequently Asked Questions specific to COVID-19 and patients who have […]
The Young Academic Urologists (YAU) declared Dr. Juan Gómez Rivas (ES) as its new Chairman after online elections were held from 15 to 17 May 2020. About 78 YAU members viewed the candidates’ video presentations and received links where to cast their votes. Dr. Gómez Rivas succeeded Prof. Selçuk Silay (TR) and will serve a four-year term. In […]
The European Association of Urology (EAU) is searching for a new Chairman to lead its EAU Patient Information (PI) department. He/she must have a keen interest in new developments and current trends in patient information, health literacy and patient advocacy. About EAU PI EAU PI provides patients clear and reliable information about their disease and […]
OPEN TO ALL PUA MEMBERS Please join us on MAY 15, 10am for PESinar 2 on: E-CONSULTATION FOR UROLOGISTS: HOW I DO IT
